FEATURED ARTICLES

• The Real Reason Sites Haven't Digitized

  Reducing site burden doesn’t always require major change. Streamlining a single workflow can improve efficiency, strengthen compliance, and give site staff more time to focus on patients and trial execution.

• The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation

  Clinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.

• Why Site Training Still Slows Site Activation

  Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.

• Your CRAs Aren't Monitoring. They're Managing Workarounds.

  CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• Fear Isn't A Strategy: Rethinking AI In Clinical Trials

  As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.

• 5 Questions Every Sponsor Must Ask Before Selecting An eTMF Platform

  Lean teams need a strategic eTMF choice. The right platform speeds startup, cuts manual oversight, strengthens site collaboration, and keeps studies inspection‑ready as portfolios grow.

• Redefining Site Feasibility

  Site feasibility is becoming a major source of startup delays as early requests, pre‑award outreach, and unclear communication create inaccurate projections and wasted effort.

• 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives

  AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

• State Of Clinical Trial Technology: The AI Inflection Point

  Digital maturity gaps are widening in clinical research. Connected workflows speed insights and execution, while manual processes leave organizations increasingly behind.